LGALS3 and type 2 diabetes mellitus: Tan et al. analyzed a cohort of T2DM patients demonstrating that high levels of Gal-3 are associated with adverse CV outcomes such as non-fatal myocardial infarction, stroke, coronary revascularization, and mortality, independent of traditional risk factors [58].